Filter
|
|
|
|
|
|
GSE216671
|
|
|
|
GSM6685565
|
in vitro, control splenic CD4+ T, 1
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685566
|
in vitro, control splenic CD4+ T, 2
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685567
|
in vitro, lycorine treated splenic CD4+ T, 1
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685568
|
in vitro, lycorine treated splenic CD4+ T, 2
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685569
|
in vitro, control CD4+ T, 1
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685570
|
in vitro, control CD4+ T, 2
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685571
|
in vitro, control CD4+ T, 3
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685572
|
in vitro, control CD4+ T, 4
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685573
|
in vitro, lycorine treated CD4+ T, 1
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685574
|
in vitro, lycorine treated CD4+ T, 2
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685575
|
in vitro, lycorine treated CD4+ T, 3
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685576
|
in vitro, lycorine treated CD4+ T, 4
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685577
|
in vitro, control CD8+ T, 1
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685578
|
in vitro, control CD8+ T, 2
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685579
|
in vitro, control CD8+ T, 3
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685580
|
in vitro, control CD8+ T, 4
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685581
|
in vitro, lycorine treated CD8+ T, 1
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685582
|
in vitro, lycorine treated CD8+ T, 2
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685583
|
in vitro, lycorine treated CD8+ T, 3
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|
GSM6685584
|
in vitro, lycorine treated CD8+ T, 4
|
SRA
|
|
1 |
|
-
GSE216671
|
|
Xiaosheng Tan
|
Jun 07, 2023
|